Cited by 761Virus-based gene therapy researchRNA Interference and Gene DeliveryBacteriophages and microbial interactions

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.

Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors

Open access

Ferrari, F K, Samulski, T, Shenk, T, Samulski, R J·1996·Journal of Virology

DOI 10.1128/jvi.70.5.3227-3234.1996PMC PMC190186

Open this paper in CoChat — free account

Abstract

The ability of recombinant adeno-associated virus (AAV) to transduce cells with a marker gene in vitro was found to be substantially increased by the presence of adenovirus. Transfection experiments with adenovirus genomic DNA suggest that this increase is not facilitated by adenovirus-mediated viral uptake but is instead dependent on adenovirus gene expression. Using various adenovirus mutants, we were able to map this function to early-region E4 open reading frame 6. Plasmid expression of open reading frame 6 protein in cells infected with recombinant AAV increased transduction between 100- and 1,000-fold. The increase in transduction was not dependent on the recombinant AAV gene cassette but instead appeared to involve an immediate early step of the AAV life cycle. Chemical and physical agents that have been shown to induce helper-free replication of wild-type AAV were also able to stimulate recombinant AAV transduction, suggesting that the phenomenon might affect AAV DNA replication. Further experiments showed that viral uncoating was not affected and that the rate-limiting step involved synthesis of a second strand on the single-stranded genomic AAV DNA. These data suggest that the adenovirus E4 region, as well as chemical and physical agents, can play an essential role in an immediate-early step of the AAV life cycle, specifically in second-strand synthesis, and have important implications for the use of AAV vectors in gene therapy protocols.

Integrity signals

Registry

Crossref · 10.1128/jvi.70.5.3227-3234.1996

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Use of a recombinant retrovirus to study post‐implantation cell lineage in mouse embryos.
Sanes, J. R., Rubenstein, J. L. R., & Nicolas, J. F. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04620.x · Cited by 1,116
Untitled work
(1952) · Cancer Research · Cited by 987
Site-specific integration by adeno-associated virus.
Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., & Berns, K. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2211 · Cited by 906
Self-citation
Site-specific integration by adeno-associated virus.
Linden, R. M., Ward, P., Giraud, C., Winocour, E., & Berns, K. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11288 · Cited by 805
Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells
Jones, N. C., & Shenk, T. E. (1979) · Cell · doi:10.1016/0092-8674(79)90275-7 · Cited by 784
Self-citation
Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.
Samulski, R. J., Zhu, X., Xiao, X., Brook, J. D., Housman, D. E., Epstein, N., & Hunter, L. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04964.x · Cited by 783
Self-citation
Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression
Samulski, R. J., Chang, L., & Shenk, T. E. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3822-3828.1989 · Cited by 742
Self-citation

Show all 46 references

Sorted by citations

Items 201–300 of 758

Adeno-Associated Virus Type 2-Mediated Transduction of Human Monocyte-Derived Dendritic Cells: Implications for Ex Vivo Immunotherapy
Ponnazhagan, S., Mahendra, G., Curiel, D. T., & Shaw, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9493-9501.2001 · Cited by 84
Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line
Malik, P., McQuiston, S. A., Yu, X., Pepper, K. A., Krall, W. J., Podsakoff, G. M., Kurtzman, G. J., & Kohn, D. B. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.1776-1783.1997 · Cited by 83
Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis
Jiang, Q., & Engelhardt, J. F. (1998) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200158 · Cited by 83
Role of the Adenovirus DNA-Binding Protein in In Vitro Adeno-Associated Virus DNA Replication
Ward, P., Dean, F. B., O’Donnell, M. E., & Berns, K. I. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.420-427.1998 · Cited by 83
Cloning and Characterization of a Bovine Adeno-Associated Virus
Schmidt, M., Katano, H., Bossis, I., & Chiorini, J. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6509-6516.2004 · Cited by 83
Adeno-associated virus for cancer gene therapy.
Ponnazhagan, S., Curiel, D. T., Shaw, D. R., Alvarez, R. D., & Siegal, G. P. (2001) · PubMed · Cited by 82
Liver induced transgene tolerance with AAV vectors
Keeler, G. D., Markusic, D. M., & Hoffman, B. E. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.002 · Cited by 81
Gene therapy for retinal disease
McClements, M. E., & MacLaren, R. E. (2013) · Translational Research · doi:10.1016/j.trsl.2012.12.007 · Cited by 80
Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin.
Ma, H., Guo, P., Li, J., Lin, S. Z., Chiang, Y. H., Xiao, X., & Cheng, S.-Y. (2002) · PubMed · Cited by 79
Cellular transduction mechanisms of adeno-associated viral vectors
Berry, G. E., & Asokan, A. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.08.001 · Cited by 90
Systemic gene delivery to the central nervous system using Adeno-associated virus
Bourdenx, M., Dutheil, N., Bézard, E., & Dehay, B. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00050 · Cited by 84
Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina
Grant, C. A., Ponnazhagan, S., Wang, X.-S., Srivastava, A., & Li, T. (1997) · Current Eye Research · doi:10.1076/ceyr.16.9.949.5046 · Cited by 79
The Interaction of Heparin Sulfate and Adeno-Associated Virus 2
Qiu, J., Handa, A., Kirby, M., & Brown, K. E. (2000) · Virology · doi:10.1006/viro.2000.0205 · Cited by 79
Terminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteins
Lovric, J., Mano, M., Zentilin, L., Eulalio, A., Zacchigna, S., & Giacca, M. (2012) · Molecular Therapy · doi:10.1038/mt.2012.144 · Cited by 77
Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) models
Chowdhury, E. A., Meno‐Tetang, G. M. L., Chang, H. Y., Wu, S., Huang, H. W., Jamier, T., Chandran, J. S., & Shah, D. K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.017 · Cited by 80
Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS
Franz, C. K., Federici, T., Yang, J., Backus, C., Oh, S. S., Teng, Q., Carlton, E. F., Bishop, K. M., Gasmi, M., Bartus, R. T., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.003 · Cited by 77
Gene therapy for Mucopolysaccharidoses
Sawamoto, K., Chen, H.-H., Alméciga-Díaz, C. J., Mason, R. W., & Tomatsu, S. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.12.434 · Cited by 78
The impact of pre-existing immunity on the non-clinical pharmacodynamics of AAV5-based gene therapy
Long, B. R., Sandza, K., Holcomb, J., Crockett, L., Hayes, G. M., Arens, J., Fonck, C., Tsuruda, L. S., Schweighardt, B., O’Neill, C. A., et al. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.03.006 · Cited by 75
Expression of Human Factor VIII by Splicing between Dimerized AAV Vectors
Chao, H., Sun, L., Bruce, A., Xiao, X., & Walsh, C. E. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0607 · Cited by 75
Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model
Igarashi, T., Miyake, K., Kato, K., Watanabe, A., Ishizaki, M., Ohara, K., & Shimada, T. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301878 · Cited by 75
Extracellular signal‐regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo
Pernet, V., Hauswirth, W. W., & Polo, A. D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03002.x · Cited by 76
Transduction of Well-Differentiated Airway Epithelium by Recombinant Adeno-Associated Virus Is Limited by Vector Entry
Bals, R., Xiao, W., Sang, N., Weiner, D. J., Meegalla, R. L., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6085-6088.1999 · Cited by 74
Adeno-Associated Virus Capsid Proteins May Play a Role in Transcription and Second-Strand Synthesis of Recombinant Genomes
Salganik, M., Aydemir, F., Nam, H.-J., McKENNA, R. V., Agbandje‐McKenna, M., & Muzyczka, N. (2013) · Journal of Virology · doi:10.1128/jvi.02093-13 · Cited by 73
Improved Adeno-Associated Virus Vector Production with Transfection of a Single Helper Adenovirus Gene, E4orf6
Allen, J. M., Halbert, C. L., & Miller, A. D. (2000) · Molecular Therapy · doi:10.1006/mthe.1999.0010 · Cited by 73
Second-Strand Genome Conversion of Adeno-Associated Virus Type 2 (AAV-2) and AAV-5 Is Not Rate Limiting following Apical Infection of Polarized Human Airway Epithelia
Ding, W., Yan, Z., Žák, R., Saavedra, M. T., Rodman, D. M., & Engelhardt, J. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7361-7366.2003 · Cited by 72
Factors Influencing Adeno-Associated Virus-Mediated Gene Transfer to Human Cystic Fibrosis Airway Epithelial Cells: Comparison with Adenovirus Vectors
Teramoto, S., Bartlett, J. S., McCarty, D. M., Xiao, X., Samulski, R. J., & Boucher, R. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8904-8912.1998 · Cited by 73
Self-citation
Cytoplasmic Trafficking of the Canine Parvovirus Capsid and Its Role in Infection and Nuclear Transport
Vihinen‐Ranta, M., Yuan, W., & Parrish, C. R. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4853-4859.2000 · Cited by 72
Intra‐articular gene delivery and expression of interleukin‐1Ra mediated by self‐complementary adeno‐associated virus
Kay, J. D., Gouze, E., Oligino, T., Gouze, J.-N., Watson, R., Levings, P. P., Bush, M. L., Dacanay, A., Nickerson, D. M., Robbins, P. D., et al. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1334 · Cited by 72
Adeno-associated Virus: A Key to the Human Genome?
Henckaerts, E., & Linden, R. M. (2010) · Future Virology · doi:10.2217/fvl.10.48 · Cited by 71
Oligodendrocyte-specific gene expression in mouse brain: Use of a myelin-forming cell type-specific promoter in an adeno-associated virus
Chen, H., McCarty, D. M., Bruce, A. T., Suzuki, K., & Suzuki, K. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990215)55:4 · Cited by 71
Gene Therapy for Lung Disease: Hype or Hope?
Albelda, S. Μ., Wiewrodt, R. G., & Zuckerman, J. B. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-8-200004180-00008 · Cited by 71
The next step in gene delivery: Molecular engineering of adeno-associated virus serotypes
Wang, J., Faust, S. M., & Rabinowitz, J. E. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.017 · Cited by 69
Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors
Zeltner, N., Kohlbrenner, E., Clément, N., Weber, T., & Linden, R. M. (2010) · Gene Therapy · doi:10.1038/gt.2010.27 · Cited by 75
Gene Delivery in Renal Tubular Epithelial Cells Using Recombinant Adeno-Associated Viral Vectors
Chen, S., Agarwal, A., Glushakova, O. Y., Scott-Jorgensen, M., Salgar, S. K., Poirier, A. E., Flotte, T. R., Croker, B. P., Madsen, K., Atkinson, M. A., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000057858.45649.f7 · Cited by 70
Hybrid vector designs to control the delivery, fate and expression of transgenes
Lam, P. Y. P., & Breakefield, X. O. (2000) · The Journal of Gene Medicine · doi:10.1002/1521-2254(200011/12)2:6 · Cited by 29
Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors
Zhao, W., Li, Z., Wu, J., Chen, L., Qing, K., Weigel-Kelley, K. A., Larsen, S. H., Shou, W., Warrington, K. H., & Srivastava, A. (2006) · Virology · doi:10.1016/j.virol.2006.04.042 · Cited by 67
Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications
Schön, C., Biel, M., & Michalakis, S. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.009 · Cited by 72
The Role of DNA-PKcs and Artemis in Opening Viral DNA Hairpin Termini in Various Tissues in Mice
Inagaki, K., Ma, C., Storm, T. A., Kay, M. A., & Nakai, H. (2007) · Journal of Virology · doi:10.1128/jvi.01225-07 · Cited by 70
The Rep Protein of Adeno-Associated Virus Type 2 Interacts with Single-Stranded DNA-Binding Proteins That Enhance Viral Replication
Stracker, T. H., Cassell, G. D., Ward, P., Loo, Y., van Breukelen, B., Carrington-Lawrence, S. D., Hamatake, R. K., van der Vliet, P. C., Weller, S. K., Melendy, T., et al. (2003) · Journal of Virology · doi:10.1128/jvi.78.1.441-453.2004 · Cited by 67
Adeno-Associated Virus-Based Vectors in Gene Therapy
Tal, J. (2000) · Journal of Biomedical Science · doi:10.1007/bf02253246 · Cited by 67
Adeno-Associated Virus Genome Interactions Important for Vector Production and Transduction
Maurer, A. C., & Weitzman, M. D. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.069 · Cited by 67
Critical assessment of current adeno-associated viral vector production and quantification methods
Aucoin, M. G., Perrier, M., & Kamen, A. (2007) · Biotechnology Advances · doi:10.1016/j.biotechadv.2007.09.001 · Cited by 65
Cardiac gene therapy with SERCA2a: From bench to bedside
Gwathmey, J. K., Yerevanian, A. I., & Hajjar, R. J. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.11.011 · Cited by 66
Adeno-Associated Virus Type 2-Mediated Gene Transfer: Role of Cellular T-Cell Protein Tyrosine Phosphatase in Transgene Expression in Established Cell Lines In Vitro and Transgenic Mice In Vivo
Qing, K., Li, W., Li, Z., Tan, M., Hansen, J. J., Weigel-Kelley, K. A., Chen, L., Yöder, M. C., & Srivastava, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.4.2741-2746.2003 · Cited by 62
Mechanistic insights into the enhancement of adeno-associated virus transduction by proteasome inhibitors
Mitchell, A. M., & Samulski, R. J. (2013) · Journal of Virology · doi:10.1128/jvi.01826-13 · Cited by 63
Self-citation
In Vitro Packaging of Adeno-Associated Virus DNA
Zhou, X., & Muzyczka, N. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3241-3247.1998 · Cited by 63
High-Level Globin Gene Expression Mediated by a Recombinant Adeno-Associated Virus Genome That Contains the 3′ γ Globin Gene Regulatory Element and Integrates as Tandem Copies in Erythroid Cells
Hargrove, P. W., Vanin, E. F., Kurtzman, G. J., & Nienhuis, A. W. (1997) · Blood · doi:10.1182/blood.v89.6.2167 · Cited by 63
Direct Gene Therapy for Bone Regeneration: Gene Delivery, Animal Models, and Outcome Measures
Pelled, G., Ben‐Arav, A., Hock, C., Reynolds, D. G., Yazıcı, C., Zilberman, Y., Gazit, Z., Awad, H. A., Gazit, D., & Schwarz, E. M. (2010) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2009.0156 · Cited by 62
Safety of adeno-associated virus gene therapy vectors: a current evaluation
Monahan, P. E., Jooss, K. U., & Sands, M. S. (2002) · Expert Opinion on Drug Safety · doi:10.1517/14740338.1.1.79 · Cited by 61
Adeno-Associated Virus Site-Specific Integration and AAVS1 Disruption
Hamilton, H., Gomos, J. B., Berns, K. I., & Falck-Pedersen, E. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.7874-7882.2004 · Cited by 67
Homologous recombination is required for AAV-mediated gene targeting
Vasileva, A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl455 · Cited by 62
Loss of ATM Function Enhances Recombinant Adeno-Associated Virus Transduction and Integration through Pathways Similar to UV Irradiation
Şanlıoğlu, S., Benson, P. K., & Engelhardt, J. F. (2000) · Virology · doi:10.1006/viro.1999.0137 · Cited by 61
Nuclear Export of Adenovirus RNA
Dobner, T., & Kzhyshkowska, J. G. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-56597-7_2 · Cited by 61
Native Molecular State of Adeno-Associated Viral Vectors Revealed by Single-Molecule Sequencing
Kapranov, P., Chen, L., Dederich, D. A., Dong, B., He, J., Steinmann, K. E., Moore, A. R., Thompson, J. F., Milos, P. M., & Xiao, W. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.160 · Cited by 58
Long-Term Rescue of Rat Retinal Ganglion Cells and Visual Function by AAV-Mediated BDNF Expression after Acute Elevation of Intraocular Pressure
Ren, R., Li, Y., Liu, Z., Liu, K., & He, S. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8484 · Cited by 60
Two Independent Molecular Pathways for Recombinant Adeno-Associated Virus Genome Conversion Occur after UV-C and E4orf6 Augmentation of Transduction
Şanlıoğlu, S., Duan, D., & Engelhardt, J. F. (1999) · Human Gene Therapy · doi:10.1089/10430349950018661 · Cited by 60
Immunomodulation in Administration of RAAV: Preclinical and Clinical Adjuvant Pharmacotherapies
Chu, W. S., & Ng, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658038 · Cited by 59
Manufacturing Clinical Grade Recombinant Adeno-Associated Virus Using Invertebrate Cell Lines
Kotin, R. M., & Snyder, R. O. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.042 · Cited by 59
Impaired Nuclear Transport and Uncoating Limit Recombinant Adeno-Associated Virus 2 Vector-Mediated Transduction of Primary Murine Hematopoietic Cells
Li, Z., Li, W., Yang, Z., Qing, K., Tan, M., Hansen, J. J., Li, Y., Chen, L., Chan, R. J., Bischof, D., et al. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1207 · Cited by 56
Ocular gene transfer with self-complementary AAV vectors
Yokoi, K., Kachi, S., Zhang, H. S., Gregory, P. D., Spratt, S. K., Samulski, R. J., & Campochiaro, P. A. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-1306 · Cited by 58
Self-citation
Natural Adeno-Associated Virus Serotypes and Engineered Adeno-Associated Virus Capsid Variants: Tropism Differences and Mechanistic Insights
López-Gordo, E., Chamberlain, K., Riyad, J. M., Kohlbrenner, E., & Weber, T. (2024) · Viruses · doi:10.3390/v16030442 · Cited by 68
Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells
Cheng, B., Ling, C., Dai, Y., Lu, Y., Glushakova, L. G., Gee, S. W. Y., McGoogan, K. E., Aslanidi, G., Park, M., Stacpoole, P. W., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.105 · Cited by 59
Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus
Sarra, G., Stephens, C., Schlichtenbrede, F. C., Bainbridge, J. W., Thrasher, A. J., Luthert, P. J., & Ali, R. R. (2002) · Vision Research · doi:10.1016/s0042-6989(01)00230-9 · Cited by 58
The Role of Recombinant AAV in Precise Genome Editing
Bijlani, S., Pang, K. M., Sivanandam, V., Singh, A., & Chatterjee, S. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.799722 · Cited by 63
Gene therapy for hemophilia
Herzog, R. W. (2015) · Frontiers in bioscience · doi:10.2741/4324 · Cited by 56
Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands
Kirik, D., Cederfjäll, E. A., Halliday, G. M., & Petersén, Å. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.008 · Cited by 57
Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness
Khalin, I., Kocherga, G., Bakar, M. A., & Alyautdin, R. N. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s77480 · Cited by 61
Stability and Safety of an AAV Vector for Treating RPGR-ORF15 X-Linked Retinitis Pigmentosa
Deng, W., Dyka, F. M., Dinculescu, A., Li, J., Zhu, P., Chiodo, V. A., Boye, S. L., Conlon, T. J., Erger, K. E., Cossette, T. L., et al. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.035 · Cited by 55
Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa
Wert, K. J., Davis, R. J., Sancho-Pellúz, J., Nishina, P. M., & Tsang, S. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds466 · Cited by 57
High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo
Song, L., Li, X., Jayandharan, G. R., Wang, Y., Aslanidi, G., Ling, C., Li, Z., Gao, G., Yöder, M. C., Ling, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058757 · Cited by 55
Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases
Rittiner, J. E., Moncalvo, M., Chiba‐Falek, O., & Kantor, B. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00148 · Cited by 53
AAV Serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect
Su, H., Huang, Y.-W., Takagawa, J., Bárcena, A., Arakawa-Hoyt, J. S., Ye, J., Grossman, W., & Kan, Y. W. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302787 · Cited by 51
Adeno-Associated Virus RNAs Appear in a Temporal Order and Their Splicing Is Stimulated during Coinfection with Adenovirus
Mouw, M. B., & Pintel, D. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.9878-9888.2000 · Cited by 53
Helper‐independent and AAV‐ITR‐independent chromosomal integration of double‐stranded linear DNA vectors in mice
Nakai, H., Montini, E., Fuess, S., Storm, T. A., Meuse, L., Finegold, M., Grompe, M., & Kay, M. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00023-0 · Cited by 52
Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse
Kong, F., Li, W., Li, X., Zheng, Q., Dai, X., Zhou, X., Boye, S. L., Hauswirth, W. W., Qu, J., & Pang, J. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.01.011 · Cited by 52
Assessment of genome packaging in AAVs using Orbitrap-based charge-detection mass spectrometry
Wörner, T. P., Snijder, J., Friese, O. V., Powers, T. W., & Heck, A. J. R. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.11.013 · Cited by 52
Mechanisms of AAV transduction in glaucoma‐associated human trabecular meshwork cells
Borrás, T., Xue, W., Choi, V. W., Bartlett, J. S., Li, G., Samulski, R. J., & Chisolm, S. S. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.886 · Cited by 51
Self-citation
Recent advances in recombinant adeno-associated virus vector production
Clark, K. R. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.0610s1009.x · Cited by 52
Adeno-Associated Virus Vectors for Therapeutic Gene Transfer
Stilwell, J. L., & Samulski, R. J. (2003) · BioTechniques · doi:10.2144/03341dd01 · Cited by 52
Self-citation
Direct interaction of human serum proteins with AAV virions to enhance AAV transduction: immediate impact on clinical applications
Wang, M., Sun, J., Crosby, A. J., Woodard, K., Hirsch, M. L., Samulski, R. J., & Li, C. (2016) · Gene Therapy · doi:10.1038/gt.2016.75 · Cited by 52
Self-citation
Transduction of human neural progenitor cells using recombinant adeno-associated viral vectors
Wu, P., Ye, Y., & Svendsen, C. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301646 · Cited by 51
Accurate Titration of Infectious AAV Particles Requires Measurement of Biologically Active Vector Genomes and Suitable Controls
François, A., Bouzelha, M., Lecomte, E., Broucque, F., Penaud-Budloo, M., Adjali, O., Moullier, P., Blouin, V., & Ayuso, E. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.07.004 · Cited by 50
Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
Bastola, P., Song, L., Gilger, B. C., & Hirsch, M. L. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12080767 · Cited by 52
Adenovirus Degradation of Cellular Proteins
Schreiner, S., Wimmer, P., & Dobner, T. (2012) · Future Microbiology · doi:10.2217/fmb.11.153 · Cited by 53
AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice
Hennig, A. K., Ogilvie, J. M., Ohlemiller, K. K., Timmers, A. M., Hauswirth, W. W., & Sands, M. S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.03.018 · Cited by 49
Recombinant adeno-associated virus vectors for gene therapy
Conlon, T. J., & Flotte, T. R. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.7.1093 · Cited by 49
Heat-shock Treatment-mediated Increase in Transduction by Recombinant Adeno-associated Virus 2 Vectors Is Independent of the Cellular Heat-shock Protein 90
Li, Z., Qing, K., Si, Y. C., Chen, L., Tan, M., & Srivastava, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310548200 · Cited by 48
Insight into the mechanism of inhibition of adeno-associated virus by the Mre11/Rad50/Nbs1 complex
Lentz, T. B., & Samulski, R. J. (2015) · Journal of Virology · doi:10.1128/jvi.01990-14 · Cited by 48
Self-citation
Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens
Nicolson, S. C., Li, C., Hirsch, M. L., Setola, V., & Samulski, R. J. (2016) · Journal of Virology · doi:10.1128/jvi.02953-15 · Cited by 48
Self-citation
An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses
Schreiber, C. A., Sakuma, T., Izumiya, Y., Holditch, S. J., Hickey, R., Bressin, R. K., Basu, U., Koide, K., Asokan, A., & Ikeda, Y. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005082 · Cited by 49
Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing
Hanson, B., Wood, M. J. A., & Roberts, T. C. (2021) · RNA Biology · doi:10.1080/15476286.2021.1874161 · Cited by 49
AAV Exploits Subcellular Stress Associated with Inflammation, Endoplasmic Reticulum Expansion, and Misfolded Proteins in Models of Cystic Fibrosis
Johnson, J. S., Gentzsch, M., Zhang, L., Ribeiro, C. M. P., Kantor, B., Kafri, T., Pickles, R. J., & Samulski, R. J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002053 · Cited by 49
Self-citation
Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer
Malik, A. K., Monahan, P. E., Allen, D. L., Chen, B.-G., Samulski, R. J., & Kurachi, K. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3555-3565.2000 · Cited by 48
Self-citation
High-Titer Recombinant Adeno-Associated Virus Production from Replicating Amplicons and Herpes Vectors Deleted for Glycoprotein H
Zhang, X., de Alwis, M., Hart, S. L., Fitzke, F. W., Inglis, S. C., Boursnell, M. E. G., Levinsky, R. J., Kinnon, C., Ali, R. R., & Thrasher, A. J. (1999) · Human Gene Therapy · doi:10.1089/10430349950016861 · Cited by 48
The potential of gene therapy in the treatment of hepatocellular carcinoma
Qian, C., Droździk, M., Caselmann, W. H., & Prìeto, J. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80082-3 · Cited by 48
Enhanced Transgene Expression from Recombinant Single-Stranded D-Sequence-Substituted Adeno-Associated Virus Vectors in Human Cell Lines In Vitro and in Murine Hepatocytes In Vivo
Ling, C., Wang, Y., Lu, Y., Wang, L., Jayandharan, G. R., Aslanidi, G. V., Li, B., Cheng, B., Ma, W., Lentz, T., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02581-14 · Cited by 47
Self-citation
Gene therapy methods in bone and joint disorders
Ulrich‐Vinther, M. (2007) · Acta Orthopaedica · doi:10.1080/17453690610046512 · Cited by 47
Adeno-Associated Viral Vector-Mediated Expression of Endostatin Inhibits Tumor Growth and Metastasis in an Orthotropic Pancreatic Cancer Model in Hamsters
Noro, T., Miyake, K., Suzuki-Miyake, N., Igarashi, T., Uchida, E., Misawa, T., Yamazaki, Y., & Shimada, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1296 · Cited by 47
Light-activated gene transduction of recombinant adeno-associated virus in human mesenchymal stem cells
Ito, H., Goater, J. J., Tiyapatanaputi, P., Rubery, P. T., O'Keefe, R. J., & Schwarz, E. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302102 · Cited by 47
Phase I/II Trial of Diaphragm Delivery of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase (rAAV1-CMV- GAA ) Gene Vector in Patients with Pompe Disease
Byrne, B. J., Smith, B. K., Mah, C. S., Lawson, L. A., Islam, S., Corti, M., Martin, D., Dobija, N., Irwin, M. V., Conlon, T. J., et al. (2014) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2014.2514 · Cited by 45

Authors: Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J.
Affiliations: University of North Carolina at Chapel Hill (US)
ORCID: Shenk, T
Venue: Journal of Virology
Publisher: American Society for Microbiology
Published: 1996-05
Volume: 70
Issue: 5
Pages: 3227-3234
ISSN: 0022-538X (ISSN-L)
1098-5514
DOI: 10.1128/jvi.70.5.3227-3234.1996
PMC: PMC190186
OpenAlex: W2165815741
Cited by: 761
References: 46
Citations by year: 2026: 13 · 2025: 16 · 2024: 16 · 2023: 17 · 2022: 13 · 2021: 15 · 2020: 25 · 2019: 17 · 2018: 15 · 2017: 10 · 2016: 22 · 2015: 27 · 2014: 21 · 2013: 17 · 2012: 27
FWCI: 24.99
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Virology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01dk042701-06)
National Heart, Lung, and Blood Institute (HL48327, P01HL051818, HL51818)
National Institute of Diabetes and Digestive and Kidney Diseases (DK 42701)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
Keywords: recombinant adeno-associated virus vectors, viral uncoating, gene therapy vectors
MeSH terms: Dependovirus, Adenoviridae, beta-Galactosidase, Cell Line, DNA, Viral, Genetic Vectors, HeLa Cells, Humans, Kinetics, Plasmids, Recombinant Proteins, Recombination, Genetic, Transduction, Genetic, Transfection, Ultraviolet Rays, X-Rays, Gene Expression, Mutagenesis, Open Reading Frames

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks